DoW Toxic Exposures Clinical Trial Award
DoW Toxic Exposures Clinical Trial Award is offered by Defense Health Agency Contracting Activity - DHACA. Max award: Not specified. Applications close on Nov 19, 2026.
| Opportunity number | HT942526TERPCTA |
|---|---|
| Agency | Defense Health Agency Contracting Activity - DHACA |
| Status | Posted |
| Posted | May 21, 2026 |
| Closes | Nov 19, 2026 |
| Award ceiling | Not specified |
| Award floor | Not specified |
| Total program funding | $4,500,000 |
| Expected awards | 1 |
| Who can apply | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility" |
| Category | Science and Technology and other Research and Development |
Summary (excerpt)
Summary: The fiscal year 2026 (FY26) Toxic Exposures Research Program (TERP) Clinical Trial Award (CTA) mechanism supports the advancement, execution, and analysis of clinical trials with the potential to have a significant impact on the prevention, treatment, or management of symptoms, diseases or conditions associated with or resulting from military-related toxic exposures. Proposed projects may range from small proof-of-concept clinical trials…
View the official listing and apply on Grants.gov
Before you apply
- Register your organization in SAM.gov and get a UEI — it can take weeks
- Create a Grants.gov account and check eligibility in the full notice (NOFO)
- Start early; the system gets busy near deadlines
Grants closing soon · More from Defense Health Agency Contracting Activity - DHACA